Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong, +25

The Lancet

Cisplatin Versus FluorouracilMedicineMetronomic TherapyPathologyCancer Treatment +4

circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer

Yao Kong, Yuting Li, Yuming Luo, +7

Molecular Cancer

Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma

Huilin Ye, Quanbo Zhou, Shangyou Zheng, +8

Cell Death and Disease

Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer

Lusheng Wei, Huilin Ye, Guolin Li, +7

Cell Death and Disease

Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis

Xiaofeng Guo, Quanbo Zhou, Dan Su, +9

Molecular Cancer

circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis

Chonghui Hu, Renpeng Xia, Xiang Zhang, +8

Molecular Cancer

Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer

Lusheng Wei, Huilin Ye, Guolin Li, +7

Cell Death and Disease

Sdf-1/satb-1 PathwayPancreatic CancerMedicineGemcitabine ResistancePathology +9

Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients

Gaojie Liu, Jie Zhu, Menglei Yu, +17

Journal of Translational Medicine

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Shaodong Hong, Yaxiong Zhang, Gengsheng Yu, +27

Journal of Clinical Oncology

circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway

Shangyou Zheng, Chonghui Hu, Hongcao Lin, +7

Journal of Experimental & Clinical Cancer Research